MiR-222 overexpression may contribute to liver fibrosis in biliary atresia by targeting PPP2R2A

Journal of Pediatric Gastroenterology and Nutrition

Volumn 60, Issue 1, 2015, Pages 84-90

  Dong, Rui ^a   Zheng, Yijie ^a   Chen, Gong ^a   Zhao, Rui ^a   Zhou, Zhijian ^a   Zheng, Shan ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Akt signaling; biliary atresia; cell proliferation; miR 222; protein phosphatase 2A subunit B

Indexed keywords

KI 67 ANTIGEN; MICRORNA 222; PHOSPHOPROTEIN PHOSPHATASE 2A; PROTEIN KINASE B; PROTEIN PHOSPHATASE 2A SUBUNIT B; UNCLASSIFIED DRUG; AKT1 PROTEIN, HUMAN; MICRORNAS; MIRN222 MICRORNA, HUMAN; PPP2R2A PROTEIN, HUMAN; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT;

ARTICLE; BILE DUCT ATRESIA; CELL PROLIFERATION; CLINICAL ARTICLE; COMMON BILE DUCT CYST; COMPUTER MODEL; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; GENE OVEREXPRESSION; GENE REPRESSION; GENETIC LINKAGE; GENETIC TRANSFECTION; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INFANT; LIVER FIBROSIS; LX 2 CELL LINE; MALE; PRIORITY JOURNAL; STELLATE CELL; ANTAGONISTS AND INHIBITORS; BILIARY ATRESIA; CELL LINE; CYTOLOGY; DISEASE PROGRESSION; GENETICS; HEPATIC STELLATE CELLS; HUMANS; LIVER; LIVER CIRRHOSIS; METABOLISM; MODELS, BIOLOGICAL; PATHOLOGY; PHYSIOPATHOLOGY; PORTOENTEROSTOMY, HEPATIC; PROSPECTIVE STUDIES; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UP-REGULATION;

BILIARY ATRESIA; CELL LINE; CELL PROLIFERATION; DISEASE PROGRESSION; FEMALE; HEPATIC STELLATE CELLS; HUMANS; INFANT; LIVER; LIVER CIRRHOSIS; MALE; MICRORNAS; MODELS, BIOLOGICAL; PORTOENTEROSTOMY, HEPATIC; PROSPECTIVE STUDIES; PROTEIN PHOSPHATASE 2; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION; UP-REGULATION;

EID: 84920864222     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0000000000000573     Document Type: Article

References (31)

1. Hartley JL, Davenport M, Kelly DA. Biliary atresia. Lancet 2009; 374:1704-13.
2. Santos JL, Choquette M, Bezerra JA. Cholestatic liver disease in children. Curr Gastroenterol Rep 2010;12:30-9.
3. Chang HK, Park YJ, Koh H, et al. Hepatic fibrosis scan for liver stiffness score measurement: a useful preendoscopic screening test for the detection of varices in postoperative patients with biliary atresia. J Pediatr Gastroenterol Nutr 2009;49:323-8.
4. Zheng Y, Xiong S, Jiang P, et al. Glucocorticoids inhibit lipopolysaccharide-mediated inflammatory response by downregulating micro-RNA-155: a novel anti-inflammation mechanism. Free Radic Biol Med 2012;52:1307-17.
5. Xiong S, Zheng Y, Jiang P, et al. MicroRNA-7 inhibits the growth of human non-small cell lung cancer A549 cells through targeting BCL-2. Int J Biol Sci 2011;7:805-14.
6. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004;116:281-97.
7. Krek A, Grun D, Poy MN, et al. Combinatorial microRNA target predictions. Nat Genet 2005;37:495-500.
8. Shen WJ, Dong R, Chen G, et al. microRNA-222 modulates liver fibrosis in a murine model of biliary atresia. Biochem Biophys Res Commun 2014;446:155-9.
9. Tugues S, Fernandez-Varo G, Munoz-Luque J, et al. Antiangiogenic treatment with sunitinib ameliorates inflammatory infiltrate, fibrosis, and portal pressure in cirrhotic rats. Hepatology 2007;46:1919-26.
10. Xu L, Hui AY, Albanis E, et al. Human hepatic stellate cell lines, LX-1 and LX-2: new tools for analysis of hepatic fibrosis. Gut 2005;54:142-51.
11. Griffiths-Jones S, Saini HK, van Dongen S, et al. miRBase: tools for microRNA genomics. Nucleic Acids Res 2008;36:D154-8.
12. Lewis BP, Shih IH, Jones-RhoadesMW, et al. Prediction of mammalian microRNA targets. Cell 2003;115:787-98.
13. Rehmsmeier M, Steffen P, Hochsmann M, et al. Fast and effective prediction of microRNA/target duplexes. RNA 2004;10:1507-17.
14. Limketkai BN, Mehta SH, Sutcliffe CG, et al. Relationship of liver disease stage and antiviral therapy with liver-related events and death in adults coinfected with HIV/HCV. JAMA 2012;308:370-8.
15. Kuo YC, Huang KY, Yang CH, et al. Regulation of phosphorylation of Thr-308 of Akt, cell proliferation, and survival by the B55alpha regulatory subunit targeting of the protein phosphatase 2A holoenzyme to Akt. J Biol Chem 2008;283:1882-92.
16. Song G, Ouyang G, Bao S. The activation of Akt/PKB signaling pathway and cell survival. J Cell Mol Med 2005;9:59-71.
17. Haafiz AB. Liver fibrosis in biliary atresia. Expert Rev Gastroenterol Hepatol 2010;4:335-43.
18. Mormone E, George J, Nieto N. Molecular pathogenesis of hepatic fibrosis and current therapeutic approaches. Chem Biol Interact 2011;193:225-31.
19. Elsharkawy AM, Oakley F, Mann DA. The role and regulation of hepatic stellate cell apoptosis in reversal of liver fibrosis. Apoptosis 2005;10:927-39.
20. Zahm AM, Hand NJ, Boateng LA, et al. Circulating microRNA is a biomarker of biliary atresia. J Pediatr Gastroenterol Nutr 2012;55:366-9.
21. Hand NJ, Horner AM, Master ZR, et al. MicroRNA profiling identifies miR-29 as a regulator of disease-Associated pathways in experimental biliary atresia. J Pediatr Gastroenterol Nutr 2012;54:186-92.
22. Ogawa T, Enomoto M, Fujii H, et al. MicroRNA-221/222 upregulation indicates the activation of stellate cells and the progression of liver fibrosis. Gut 2012;61:1600-9.
23. Huang JF, Chuang YH, Dai CY, et al. Hepatic Akt expression correlates with advanced fibrosis in patients with chronic hepatitis C infection. Hepatol Res 2011;41:430-6.
24. Wu CF, Lin YL, Huang YT. Hepatitis C virus core protein stimulates fibrogenesis in hepatic stellate cells involving the obese receptor. J Cell Biochem 2013;114:541-50.
25. O'Shaughnessy RF, Welti JC, Sully K, et al. Akt-dependent Pp2a activity is required for epidermal barrier formation during late embryonic development. Development 2009;136:3423-31.
26. Cohen PT, Brewis ND, Hughes V, et al. Protein serine/threonine phosphatases; an expanding family. FEBS Lett 1990;268:355-9.
27. Van Hoof C, Goris J. PP2A fulfills its promises as tumor suppressor: which subunits are important?. Cancer Cell 2004;5:105-6.
28. Janssens V, Longin S, Goris J. PP2A holoenzyme assembly: in cauda venenum (the sting is in the tail). Trends Biochem Sci 2008;33:113-21.
29. Chun-Zhi Z, Lei H, An-Ling Z, et al. MicroRNA-221 and microRNA-222 regulate gastric carcinoma cell proliferation and radioresistance by targeting PTEN. BMC Cancer 2010;10:367.
30. Lu Y, Xiao J, Lin H, et al. A single anti-microRNA antisense oligodeoxyribonucleotide (AMO) targeting multiple microRNAs offers an improved approach for microRNA interference. Nucleic Acids Res 2009;37:e24.
31. Esau CC. Inhibition of microRNA with antisense oligonucleotides. Methods 2008;44:55-60.